She regulates appetite, manages blood sugar, and basically runs the metabolic world
MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation, and despite strong third-quarter performances from many firms in this sector
Whether youre pushing into your 40s and 50s, dealing with brain fog, recovering from concussions, or looking to stay sharp as you age this is a deep dive into the future of brain health
Many of these improve as the body adjusts to treatment
I am 56 and had been hovering around that number for about three years after my second pregnancy
Many people continued other forms of treatment after stopping GLP-1 drugs, which may help explain why large weight regain was not commonly observed